These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 7673699

  • 1. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand.
    Chen FA, Williams SS, Fanslow WC, Bankert RB.
    J Immunol; 1995 Sep 15; 155(6):2833-40. PubMed ID: 7673699
    [Abstract] [Full Text] [Related]

  • 2. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers.
    Han S, Hathcock K, Zheng B, Kepler TB, Hodes R, Kelsoe G.
    J Immunol; 1995 Jul 15; 155(2):556-67. PubMed ID: 7541819
    [Abstract] [Full Text] [Related]

  • 3. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M, Brown SA, Tutt LM, Tan J, Seehafer DL, Harris JP, Xun CQ, Thompson JS.
    Clin Transplant; 1997 Oct 15; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [Abstract] [Full Text] [Related]

  • 4. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2.
    Grabstein KH, Maliszewski CR, Shanebeck K, Sato TA, Spriggs MK, Fanslow WC, Armitage RJ.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3141-7. PubMed ID: 7682232
    [Abstract] [Full Text] [Related]

  • 5. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S.
    Cell Immunol; 1997 Nov 25; 182(1):20-8. PubMed ID: 9427806
    [Abstract] [Full Text] [Related]

  • 6. CD40 and its ligand in the regulation of humoral immunity.
    Klaus SJ, Berberich I, Shu G, Clark EA.
    Semin Immunol; 1994 Oct 25; 6(5):279-86. PubMed ID: 7532458
    [Abstract] [Full Text] [Related]

  • 7. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI, Croft M.
    J Immunol; 1997 Sep 01; 159(5):2282-91. PubMed ID: 9278317
    [Abstract] [Full Text] [Related]

  • 8. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
    Williams SS, Umemoto T, Kida H, Repasky EA, Bankert RB.
    J Immunol; 1992 Oct 15; 149(8):2830-6. PubMed ID: 1401915
    [Abstract] [Full Text] [Related]

  • 9. CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation.
    Lane P, Burdet C, McConnell F, Lanzavecchia A, Padovan E.
    Eur J Immunol; 1995 Jun 15; 25(6):1788-93. PubMed ID: 7615009
    [Abstract] [Full Text] [Related]

  • 10. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM, Sasgary M, Ahmad RU, Auer W, Turecek PL, Schwarz HP.
    Thromb Haemost; 2001 Dec 15; 86(6):1345-52. PubMed ID: 11776297
    [Abstract] [Full Text] [Related]

  • 11. CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during an in vivo type 2 response, but is not required for T cell IL-4 production.
    Lu P, Urban JF, Zhou XD, Chen SJ, Madden K, Moorman M, Nguyen H, Morris SC, Finkelman FD, Gause WC.
    J Immunol; 1996 May 01; 156(9):3327-33. PubMed ID: 8617957
    [Abstract] [Full Text] [Related]

  • 12. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.
    Maruo S, Oh-hora M, Ahn HJ, Ono S, Wysocka M, Kaneko Y, Yagita H, Okumura K, Kikutani H, Kishimoto T, Kobayashi M, Hamaoka T, Trinchieri G, Fujiwara H.
    J Immunol; 1997 Jan 01; 158(1):120-6. PubMed ID: 8977182
    [Abstract] [Full Text] [Related]

  • 13. CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells.
    Aversa G, Punnonen J, Carballido JM, Cocks BG, de Vries JE.
    Semin Immunol; 1994 Oct 01; 6(5):295-301. PubMed ID: 7532459
    [Abstract] [Full Text] [Related]

  • 14. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW, Papayoti MH, Netto G, Armstrong DT, Ordonez G, Lawson JM, Stone MJ.
    Clin Cancer Res; 2001 Mar 01; 7(3):691-703. PubMed ID: 11297266
    [Abstract] [Full Text] [Related]

  • 15. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice.
    Wiley JA, Harmsen AG.
    J Immunol; 1995 Oct 01; 155(7):3525-9. PubMed ID: 7561048
    [Abstract] [Full Text] [Related]

  • 16. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice.
    Balasa B, Krahl T, Patstone G, Lee J, Tisch R, McDevitt HO, Sarvetnick N.
    J Immunol; 1997 Nov 01; 159(9):4620-7. PubMed ID: 9379064
    [Abstract] [Full Text] [Related]

  • 17. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
    Zhou W, Ohdan H, Tanaka Y, Hara H, Tokita D, Onoe T, Asahara T.
    Transpl Immunol; 2003 Nov 01; 12(1):9-18. PubMed ID: 14551028
    [Abstract] [Full Text] [Related]

  • 18. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen.
    Kyburz D, Corr M, Brinson DC, Von Damm A, Tighe H, Carson DA.
    J Immunol; 1999 Sep 15; 163(6):3116-22. PubMed ID: 10477577
    [Abstract] [Full Text] [Related]

  • 19. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
    Resetkova E, Kawai K, Enomoto T, Arreaza G, Togun R, Foy TM, Noelle RJ, Volpé R.
    Thyroid; 1996 Aug 15; 6(4):267-73. PubMed ID: 8875745
    [Abstract] [Full Text] [Related]

  • 20. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Buhlman J, Xu J, Flavell RA, Korngold R, Noelle R, Vallera DA.
    J Immunol; 1997 Jan 01; 158(1):29-39. PubMed ID: 8977172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.